Pooled safety analysis of zanubrutinib monotherapy in patients with B-cell malignancies

Zanubrutinib for treatment-naïve and relapsed/refractory chronic lymphocytic leukaemia: long-term follow-up of the phase I/II AU-003 study

Systemic mastocytosis associated with two clonal haematological neoplasms

Improving outcomes for patients with lymphoma: design and development of the Australian and New Zealand Lymphoma and Related Diseases Registry